- Home
- NRXP vs AIXI Comparison
NRXP vs AIXI Comparison
Compare NRXP & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- AIXI
- Stock Information
- Founded
- NRXP 2015
- AIXI 2001
- Country
- NRXP United States
- AIXI China
- Employees
- NRXP N/A
- AIXI N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- AIXI Computer Software: Prepackaged Software
- Sector
- NRXP Health Care
- AIXI Technology
- Exchange
- NRXP Nasdaq
- AIXI Nasdaq
- Market Cap
- NRXP 32.6M
- AIXI 31.2M
- IPO Year
- NRXP N/A
- AIXI 2023
- Fundamental
- Price
- NRXP $3.34
- AIXI $2.32
- Analyst Decision
- NRXP Strong Buy
- AIXI
- Analyst Count
- NRXP 4
- AIXI 0
- Target Price
- NRXP $28.50
- AIXI N/A
- AVG Volume (30 Days)
- NRXP 240.0K
- AIXI 130.2K
- Earning Date
- NRXP 08-13-2025
- AIXI 05-15-2025
- Dividend Yield
- NRXP N/A
- AIXI N/A
- EPS Growth
- NRXP N/A
- AIXI N/A
- EPS
- NRXP N/A
- AIXI N/A
- Revenue
- NRXP N/A
- AIXI $70,314,315.00
- Revenue This Year
- NRXP N/A
- AIXI $26.84
- Revenue Next Year
- NRXP N/A
- AIXI N/A
- P/E Ratio
- NRXP N/A
- AIXI N/A
- Revenue Growth
- NRXP N/A
- AIXI 18.84
- 52 Week Low
- NRXP $1.10
- AIXI $2.06
- 52 Week High
- NRXP $6.01
- AIXI $8.31
- Technical
- Relative Strength Index (RSI)
- NRXP 60.08
- AIXI 43.02
- Support Level
- NRXP $2.90
- AIXI $2.27
- Resistance Level
- NRXP $3.53
- AIXI $3.10
- Average True Range (ATR)
- NRXP 0.19
- AIXI 0.28
- MACD
- NRXP -0.03
- AIXI -0.00
- Stochastic Oscillator
- NRXP 84.13
- AIXI 28.82
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.